Kahn Brothers Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.2M Sell
2,670,523
-2,866,470
-52% -$34.3M 5.72% 6
2026
Q1
$33.2M Buy
5,536,993
+1,907,542
+53% +$14.4M 5.88% 7
2025
Q4
$26M Buy
3,629,451
+12,606
+0.3% +$99.6K 4.61% 9
2025
Q3
$38.6M Buy
3,616,845
+126,695
+4% +$1.24M 7.26% 5
2025
Q2
$33.8M Buy
3,490,150
+996,766
+40% +$10.3M 6.78% 7
2025
Q1
$37.1M Buy
2,493,384
+926,111
+59% +$14.2M 7.51% 6
2024
Q4
$23.4M Sell
1,567,273
-267,920
-15% -$4.37M 5.08% 9
2024
Q3
$35.1M Buy
1,835,193
+174,170
+10% +$3.61M 6.05% 9
2024
Q2
$34.4M Buy
1,661,023
+480,819
+41% +$9.56M 5.78% 6
2024
Q1
$22.2M Buy
1,180,204
+1,144,894
+3,242% +$19.6M 3.29% 13
2023
Q4
$509K Sell
35,310
-16,036
-31% -$218K 0.08% 27
2023
Q3
$892K Sell
51,346
-8,452
-14% -$176K 0.14% 24
2023
Q2
$1.24M Sell
59,798
-1,821
-3% -$39.6K 0.18% 21
2023
Q1
$1.45M Sell
61,619
-1,015
-2% -$27.3K 0.21% 22
2022
Q4
$1.75M Buy
62,634
+366
+0.6% +$9.36K 0.23% 21
2022
Q3
$1.46M Sell
62,268
-4,290
-6% -$130K 0.23% 21
2022
Q2
$2.25M Sell
66,558
-846
-1% -$29.6K 0.3% 18
2022
Q1
$2.35M Sell
67,404
-1,466
-2% -$50.1K 0.3% 19
2021
Q4
$2.1M Sell
68,870
-1,294
-2% -$42.1K 0.29% 18
2021
Q3
$2.3M Sell
70,164
-1,458
-2% -$46.7K 0.32% 20
2021
Q2
$2.17M Buy
+71,622
New +$2.36M 0.31% 21

Other funds holding OGN

Kahn Brothers Group's OGN Position: Q2 2026 in Review

Kahn Brothers Group reduced its Organon & Co (OGN) stake by 52% in Q2 2026, selling an estimated $34.3M and leaving 2,670,523 shares worth $36.2M. The position accounts for 5.72% of the portfolio, ranked #6.

Kahn Brothers Group first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $38.6M in Q3 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Kahn Brothers Group held 2,670,523 shares of Organon & Co worth $36.2M as of Q2 2026.
  • Kahn Brothers Group sold 2,866,470 Organon & Co shares in Q2 2026, an estimated $34.3M.
  • Organon & Co made up 5.72% of Kahn Brothers Group's portfolio in Q2 2026, its #6 holding.
  • Kahn Brothers Group first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Kahn Brothers Group's Organon & Co position peaked at $38.6M in Q3 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Kahn Brothers Group's 13F filing for Q2 2026, filed 14 Aug 2026.